Overview:
Elesta S.r.l. was founded in 2005 with the aim of developing innovative hi-tech therapeutic applications for interventional medicine. Our main product is EchoLaser: the first and unique integrated Laser-Ultrasound system that allows diagnosis and treatment of benign and malignant lesions. EchoLaser uses the laser light transmitted through extremely thin optical fibres (0,3 mm) inserted percutaneously under a proprietary ultrasound guiding system. EchoLaser Therapy can induce a cytoreduction process on benign lesions (e.g.: BPH, thyroid nodules, etc.) or destroy cancerous tissue of malignant lesions (e.g.: metastatic lymph nodes, liver cancer, etc.). Generally no general anaesthesia is required. Procedures can be performed in outpatient regimen with consequent faster recovery after treatment.
